Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease.

Thirty-five patients with bone disease and chronic renal failure (twenty-four on maintenance haemodialysis) were treated for 7--39 months with 1alpha-hydroxyvitamin D3, 2--2.5 microgram daily by mouth. Symptoms (bone pain and muscle weakness) and radiographic appearances improved and plasma alkaline...

Full description

Bibliographic Details
Main Authors: Kanis, J, Earnshaw, M, Henderson, R, Heynen, G, Ledingham, J, Naik, R, Oliver, DO, Russell, R, Smith, R, Wilkinson, R, Woods, C
Format: Journal article
Language:English
Published: 1977